University of colorado led study reports steady increases in long-term survival among children with acute lymphoblastic leukemia, reflecting impact of treatment advances

A study by the Children’s Oncology Group (COG) reported that five-year survival for acute lymphoblastic leukemia (ALL, the most common type of pediatric cancer) among children treated through COG clinical trials increased from 83.7 percent during the period 1990-1994 to 90.4 percent in the period 2000-2005. The improvements in survival were observed among all children over age 1 regardless of age, sex, ethnicity, or subtype of ALL. This analysis, which is the largest study to date of ALL survival, showed similar gains in 10-year survival. The findings were published March 12 in the Journal of Clinical Oncology., malesuada a ipsum. Nulla gravida pharetra libero nec ultricies. Click here to read full press release